Aarti Industries Limited
NSE: AARTIINDINE769A01020·ChemicalsSmallcap 250·www.aarti-industries.com ↗·Mcap ₹17,812 Cr·Listed 1995
₹489.25▼ ₹0.20  (−0.04%)
52W: ₹338 – ₹552 · Vol: 3.0L shares · Close 25 Sept
Set Alert

Quarterly results

consolidated · as filed with NSE · Q1 FY27 back to Q4 FY18
₹ croreQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25Q1 FY25Q4 FY24Q3 FY24Q2 FY24Q1 FY24Q4 FY23Q3 FY23Q2 FY23Q1 FY23Q4 FY22Q2 FY22Q1 FY22Q4 FY21Q3 FY21Q2 FY21Q1 FY21Q4 FY20Q3 FY20Q1 FY20Q4 FY18
Revenue from operations2,3872,2062,3192,1001,6761,9491,8401,6281,8551,7731,7321,4541,4141,6561,6681,6851,9721,7561,5521,3171,2091,1871,1739371,0761,2181,1350
Other income3−0.81.90.33.5−2.94.54.95.7−0.18.4000.20.300.40.20.50.100.400.20.40.42.50
Total expenses2,2122,0942,1872,0291,6371,8581,8051,6011,7161,6471,6231,3721,3421,5211,5081,5351,7391,5241,3311,1104839789968339401,0409600
EBITDA3823433212912122692321973052832602332012522892673693393103148132852541822192542500
EBITDA margin16.0%15.5%13.9%13.9%12.7%13.8%12.6%12.1%16.4%16.0%15.0%16.0%14.2%15.2%17.3%15.8%18.7%19.3%20.0%23.8%67.3%24.0%21.7%19.4%20.3%20.9%22.0%–
Finance costs8311268.510059.56485.562.463.658.95458.240.433.14743.749.830.618.538.321.617.322.225.33428.7310
Depreciation12411912112011411311110810298.397.493.189.483.782.172.986.577.271.168.665.658.7555249.34743.20
Profit before tax18011111893.541.988.5403414512611781.671.51351601502332312212077262091771051361791780
Tax25−26.2−14.4−12−1.4−7.3−6−18.38−6.1−7.5−9.11.6−13.523.425.944.337.744.741.933.740.333.721.725.736.136.50
Net profit15513713310643.395.84652.313713212490.769.814913712418919417616569216914483.21101431420
Net margin6.5%6.2%5.7%5.0%2.6%4.9%2.5%3.2%7.4%7.4%7.2%6.2%4.9%9.0%8.2%7.4%9.6%11.0%11.3%12.5%57.2%14.3%12.2%8.9%10.3%11.7%12.5%–
EPS (₹)4.273.793.672.911.190.001.271.443.773.643.422.501.934.103.773.435.225.344.864.557.819.498.054.706.338.0315.940.00
Net profit YoY+258.0%+43.3%+189.0%+101.6%−68.3%−27.4%−63.0%−42.3%+95.8%−11.3%−9.1%−27.2%−63.1%−23.3%–−29.3%+14.5%−72.0%+22.7%+98.4%+527.4%+18.5%–−41.4%––––

Annual results

financial years ending March · from the fourth-quarter filings
₹ croreFY26FY25FY24FY23FY22FY21FY20FY18
Revenue from operations8,2867,2716,3726,6197,0004,5064,1863,806
Other income4.914.18.40.90.80.78.87.8
Total expenses7,9336,9815,9856,0085,4743,8423,5193,385
EBITDA1,1681,0009771,0891,929982977699
EBITDA margin14.1%13.8%15.3%16.5%27.6%21.8%23.3%18.4%
Finance costs34027521116811486.4125132
Depreciation474434378310289231185146
Profit before tax3653073956111,527665676429
Tax−54.3−23.6−21.165.921912912982.9
Net profit4193314165451,307535547346
Net margin5.1%4.6%6.5%8.2%18.7%11.9%13.1%9.1%
EPS (₹)11.560.0011.4915.0436.0630.0430.7740.95
Net profit YoY+26.7%−20.6%−23.6%−58.3%+144.3%−2.1%––
EPS is as filed for each period and is not restated for later bonus issues or splits.

Cash flow

annual · ₹ crore
₹ croreFY26FY25FY24FY23FY22
Operating cash flow7811,2421,2041,310471
Investing cash flow−1,142−1,398−1,310−1,330−1,305
Financing cash flow745−73.23547.2679
Capital expenditure1,1241,3861,3281,3261,307
Free cash flow (CFO − capex)−343−144−124−16.4−836

Net profit trend

annual, ₹ crore
FY21
₹535
FY22
₹1,307+144%
FY23
₹545−58%
FY24
₹416−24%
FY25
₹331−21%
FY26
₹419+27%

Result filings

as filed with NSE · PDF and XBRL
PeriodBasisFiledDocuments
Q1 FY27Consolidated30 Jul 2026PDF on NSE XBRL
Q1 FY27Standalone30 Jul 2026PDF on NSE XBRL
Q4 FY26Consolidated · audited4 May 2026PDF on NSE XBRL
Q4 FY26Standalone · audited4 May 2026PDF on NSE XBRL
Q3 FY26Consolidated2 Feb 2026PDF on NSE XBRL
Q3 FY26Standalone2 Feb 2026PDF on NSE XBRL
Q2 FY26Consolidated6 Nov 2025PDF on NSE XBRL
Q2 FY26Standalone6 Nov 2025PDF on NSE XBRL
Q1 FY26Consolidated31 Jul 2025PDF on NSE XBRL
Q1 FY26Standalone31 Jul 2025PDF on NSE XBRL

Annual reports

NSE archive
Key ratios
P/E (TTM)5Y avg 42.4×33.4×
P/B5Y avg 3.52×2.98×
ROEFY26, on average equity7.3%
Net margin5.1%
Debt / equity0.83×
Revenue CAGR (3Y)7.8%
Profit CAGR (3Y)-8.4%
EPS (TTM)₹14.64
Market cap₹17,736 Cr
Computed from the filings and the last close. Market cap uses the latest share count from the balance sheet.
P/B vs history
2.98×
vs 8-point avg 3.52× (−15%)
2.38× low3.52× avg5.03× high
History points are balance-sheet dates (2022 → 2026), priced at the adjusted close on each date.
Balance sheet 31 Mar 2026
Total assets₹13,300 Cr+20%
Net worth₹5,955 Cr+6%
Total borrowings₹4,921 Cr
Cash & bank balances₹583 Cr+192%
Investments₹132 Cr+178%
Inventories₹1,732 Cr+19%
Trade receivables₹1,403 Cr+78%
Trade payables₹1,841 Cr+49%
Change vs the same date a year earlier.
Revenue mix FY22
a) Speciality Chemicals83.7%result ₹1,614 Cr
b) Pharmaceuticals16.3%result ₹220 Cr
Segment revenue as reported, before inter-segment eliminations.
Shareholding 30 Jun 2026
%Jun 26Mar 26Dec 25Sept 25Jun 25Mar 25Dec 24Sept 24Jun 24Mar 24Dec 23Sept 23
Promoter41.8242.0942.1442.1842.2442.2442.3542.6143.2443.4343.5543.57
FII6.997.386.696.406.446.297.259.6810.6110.9310.8310.57
DII21.1120.1218.2218.2120.3819.9717.9418.1318.5617.2515.8416.15
of which MF12.1211.5110.2010.2012.65–––––––
Retail25.5025.8028.2328.4626.5426.9627.8625.1323.3424.1325.4825.72
Other public4.584.614.724.754.404.544.604.454.254.264.303.99
3,70,868 shareholders · NSE shareholding pattern filings.